IBEX TECHNOLOGIES INC.: IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
13th Nov 2006, 20:53 GMT
WASHINGTON, DC and MONTREAL, QUEBEC (MARKET WIRE)
IBEX TECHNOLOGIES INC.: IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis related news:
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis — ArriveNet : Health
- Tegal Announces Settlement in Trade Secret Litigation — NSTI nanoPRwire
- FUN Technologies Files Management Discussion and Analysis — ArriveNet : Entertainment
- Health Tip: Signs That You Have Kidney Stones — KLTV - Med Team
- FUN Technologies Inc.: FUN Technologies Files Management Discussion and Analysis — Market Wire - Computers and Software
- Health Tip: Signs That You Have Kidney Stones (HealthDay) — Yahoo! Health: Health News
- Axis Technologies, Inc.: Kennebunk Schools Select Axis Technologies, Inc. Ballasts — Market Wire - Real Estate and Construction
- Topspin begins preclinical testing of prostate cancer MRI — News
- ACR: Botox Is New Wrinkle In Osteoarthritis — MedPage Today Rheumatology
- Cetek Technologies Inc: Hybrid-Tek, Inc. Reports Best Year in Past Twenty Years — Market Wire - Telecom
Latest news from Market Wire - Pharmaceuticals and Biotech:
- Qiagen N.V.: QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- Daiichi Sankyo, Inc.: First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Daiichi Sankyo, Inc.: WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
- Targeted Genetics Corporation: Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- Crucell N.V.: Crucell Announces Third Quarter 2006 Results
- Acambis PLC: Acambis PLC announces Update on US MVA procurement
- SkyePharma PLC: SkyePharma PLC announces Board Appointment
- Base Technologies, Inc.: Base Technologies Award of Air Force Surgeon General Contract Continues Rapid Growth Trend
- Eugene Science, Inc.: Eugene Science Signs Major Distribution Agreement With RexGene Biotech
- GelStat Corporation: GelStat Announces the Retention of Accomplished Business Development and Marketing Firm U.S. Marketing